At the 2025 Urology On The Beach meeting, Raveen Syan, MD, FPMRS, Course Co-Director from the Desai Sethi Urology Institute and University of Miami, highlights the key advancements in female pelvic medicine and reconstructive surgery, as well as what she hopes attendees will take away from the session on reconstructive urology. She also expands on the progress that has been made in addressing gender-specific challenges in urologic oncology. ...
Urothelial Carcinoma
Advertisement
Latest News
Dr. Syan shares her vision for the meeting and the lessons or feedback from the past two years that helped shape the program.
Dr. Lotan discusses risk stratification and outlines the next steps for integrating Cxbladder Triage into clinical practice.
Sasanlimab is being further studied in combination with other antibody drug conjugate treatments in advanced solid tumors.
The indication for SG as a treatment for patients with pretreated aUC will be officially withdrawn by Gilead.
Dr. Geynisman reviews the RETAIN 1 trial evaluating whether certain patients with MIBC can safely avoid invasive procedures.
Dr. Tyson shares insights on the potential role of cretostimogene in treating BCG-unresponsive NMIBC, based on BOND-003 data.
Advertisement
Urothelial Carcinoma Knowledge Hubs
Curated clinical content based on urothelial cancer types, therapies, and technologies
Conference Coverage
Dr. Syan shares her vision for the meeting and the lessons or feedback from the past two years that helped shape the program.
Dr. Sanchez-Salas comments on whether PSMA PET is useful for determining optimal candidates for focal therapy.
Dr. Sanchez-Salas details strategies for selecting between focal therapy versus active surveillance or definitive treatments.
Dr. Kaouk presented on the benefits of surgery for managing biochemically recurrent prostate cancer post-radiation.
Dr. Kaouk explains how a multidisciplinary team should be integrated into the management of RCC.
Dr. Karam explains the main points of emphasis when it comes to small renal masses and surveillance versus surgery.
Advertisement
Advertisement
Latest News
Dr. Syan shares her vision for the meeting and the lessons or feedback from the past two years that helped shape the program.
Dr. Sanchez-Salas comments on whether PSMA PET is useful for determining optimal candidates for focal therapy.
Dr. Sanchez-Salas details strategies for selecting between focal therapy versus active surveillance or definitive treatments.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.